Royalty Pharma (RPRX) News Today $27.97 +0.25 (+0.90%) (As of 09:01 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 16 at 5:23 AM | fool.com3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a DecadeSeptember 16 at 5:16 AM | marketbeat.comDai ichi Life Insurance Company Ltd Takes Position in Royalty Pharma plc (NASDAQ:RPRX)Dai ichi Life Insurance Company Ltd acquired a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 94,066 shares of the biopharmaceuSeptember 15 at 4:35 AM | marketbeat.comForsta AP Fonden Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Forsta AP Fonden lifted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 138.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 235,900 shares of the biopharmaceutiSeptember 13 at 5:57 AM | marketbeat.comMain Street Financial Solutions LLC Buys Shares of 45,470 Royalty Pharma plc (NASDAQ:RPRX)Main Street Financial Solutions LLC bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 45,470 shares of the biopharmaceutical company's stock, valued at approSeptember 12, 2024 | americanbankingnews.comAnalysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $42.00September 11, 2024 | marketbeat.comPrudential PLC Acquires Shares of 123,524 Royalty Pharma plc (NASDAQ:RPRX)Prudential PLC bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 123,524 shares of the biopharmaceutical company's stock, valued at approximatSeptember 10, 2024 | americanbankingnews.comRoyalty Pharma (NASDAQ:RPRX) Lowered to Hold at StockNews.comSeptember 9, 2024 | marketbeat.comStockNews.com Lowers Royalty Pharma (NASDAQ:RPRX) to HoldStockNews.com cut shares of Royalty Pharma from a "buy" rating to a "hold" rating in a report on Monday.September 9, 2024 | marketbeat.comLos Angeles Capital Management LLC Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Los Angeles Capital Management LLC lessened its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 36.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 445,548 shares of the biopharmaceutical company'sSeptember 9, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of "Moderate Buy" by BrokeragesRoyalty Pharma plc (NASDAQ:RPRX - Get Free Report) has received an average recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. TheSeptember 8, 2024 | marketbeat.comNew South Capital Management Inc. Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)New South Capital Management Inc. grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 60.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,348,977 shares ofSeptember 8, 2024 | fool.com2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100September 7, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Position Increased by Torray Investment Partners LLCTorray Investment Partners LLC grew its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 3.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 693,558 shares of the biopharmaceutical company's stSeptember 7, 2024 | finance.yahoo.comRoyalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?September 5, 2024 | marketbeat.com143,912 Shares in Royalty Pharma plc (NASDAQ:RPRX) Bought by Hohimer Wealth Management LLCHohimer Wealth Management LLC purchased a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 143,912 shares of the biopharmaceutical company's stock,September 4, 2024 | benzinga.comRare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance CutSeptember 4, 2024 | marketbeat.comRegal Partners Ltd Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Regal Partners Ltd raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 22.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,177,601 shares of the biopharmaceutical company's stocSeptember 3, 2024 | globenewswire.comRoyalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementSeptember 2, 2024 | marketbeat.comBank of New York Mellon Corp Purchases 86,248 Shares of Royalty Pharma plc (NASDAQ:RPRX)Bank of New York Mellon Corp grew its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,533,094 shares of the biopharmaceutical company's stock after acquiring an additSeptember 1, 2024 | marketbeat.comPanagora Asset Management Inc. Decreases Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Panagora Asset Management Inc. decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 67.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 63,120 shares of the biopharmaceutical company's stock after selling 129,378 shaAugust 31, 2024 | marketbeat.comSearle & CO. Acquires Shares of 57,500 Royalty Pharma plc (NASDAQ:RPRX)Searle & CO. acquired a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 57,500 shares of the biopharmaceutical company's stock, valued at approximatAugust 30, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Upgraded by StockNews.com to BuyStockNews.com upgraded Royalty Pharma from a "hold" rating to a "buy" rating in a report on Friday.August 29, 2024 | finance.yahoo.comRoyalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare ConferenceAugust 28, 2024 | globenewswire.comRoyalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare ConferenceAugust 27, 2024 | 247wallst.comGoldman Sachs Predicts a Double-Digit Rally for These 2 Growth StocksAugust 26, 2024 | finance.yahoo.comJim Cramer on Royalty Pharma plc (NASDAQ:RPRX): It’s Been a ‘Bit of a Bust, I Feel Badly’August 25, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Overbrook Management CorpOverbrook Management Corp lowered its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 4.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 200,412 shares of the biopharmaceutical company's stock after sellingAugust 24, 2024 | marketbeat.comEnvestnet Portfolio Solutions Inc. Acquires Shares of 9,616 Royalty Pharma plc (NASDAQ:RPRX)Envestnet Portfolio Solutions Inc. bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,616 shares of the biopharmaceutical company'August 23, 2024 | nz.finance.yahoo.comRoyalty Pharma plc (RPD.MU)August 23, 2024 | marketbeat.comRaymond James & Associates Has $19.35 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Raymond James & Associates decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 733,678 shares of the biopharmaceuticalAugust 22, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sees Large Volume IncreaseRoyalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeAugust 22, 2024 | seekingalpha.comRoyalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy RatingAugust 20, 2024 | marketbeat.comSumitomo Mitsui Trust Holdings Inc. Has $26.20 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 993,578 shares of the biopAugust 16, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Swedbank ABSwedbank AB boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 30.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,813,470 shares of the biopharmaceutical company's stock after purchasing an additional 2August 15, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Moderate Buy" from AnalystsShares of Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four haveAugust 13, 2024 | marketbeat.comStockNews.com Upgrades Royalty Pharma (NASDAQ:RPRX) to "Buy"StockNews.com raised shares of Royalty Pharma from a "hold" rating to a "buy" rating in a report on Tuesday.August 13, 2024 | markets.businessinsider.comBuy Rating Affirmed for Royalty Pharma Amidst Strong Financials and Positive Growth OutlookAugust 11, 2024 | seekingalpha.comDividend Champion, Contender, And Challenger Highlights: Week Of August 11August 11, 2024 | finance.yahoo.comRoyalty Pharma Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 10, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)August 10, 2024 | marketbeat.comManning & Napier Advisors LLC Purchases New Shares in Royalty Pharma plc (NASDAQ:RPRX)Manning & Napier Advisors LLC acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The fund acquired 195,853 shares of the biopharmaceutical company's stock, valued at approximately $5,1August 8, 2024 | seekingalpha.comRoyalty Pharma plc (RPRX) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Stock Price Down 4.3%Royalty Pharma (NASDAQ:RPRX) Trading Down 4.3%August 8, 2024 | seekingalpha.comRoyalty Pharma plc 2024 Q2 - Results - Earnings Call PresentationAugust 8, 2024 | investorplace.comRPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q2 2024August 8, 2024 | markets.businessinsider.comRoyalty Pharma is about to announce earnings — here's what Wall Street expectsAugust 6, 2024 | marketbeat.comAtria Investments Inc Purchases New Shares in Royalty Pharma plc (NASDAQ:RPRX)Atria Investments Inc purchased a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 39,019 shares of the biopharmaceutical company's stock,August 4, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Has $22.54 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)DekaBank Deutsche Girozentrale raised its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 58.5% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 749,344 shares of the biopharmaceutical company's stock after acquiring an additional 276,546 sharAugust 2, 2024 | marketbeat.comAdvisory Resource Group Takes Position in Royalty Pharma plc (NASDAQ:RPRX)Advisory Resource Group purchased a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 27,121 shares of the biopharmaceutical company's stock, valued at appAugust 1, 2024 | marketbeat.comRoyalty Pharma (RPRX) Set to Announce Earnings on ThursdayRoyalty Pharma (NASDAQ:RPRX) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=605397) Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. Click here and take notes. RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼0.960.69▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼94▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Nektar Therapeutics News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Vertex Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
